BPTH (Bio-Path Holdings) Cyclically Adjusted Book per Share: $149.15 (As of Mar. 2026)


What is Bio-Path Holdings Cyclically Adjusted Book per Share?

Bio-Path Holdings BPTH -19.63% Cyclically Adjusted Book per Share is $149.15 as of Mar. 2026. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bio-Path Holdings's adjusted book value per share for the three months ended in Mar. 2026 was $-0.908. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $149.15 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bio-Path Holdings's average Cyclically Adjusted Book Growth Rate was -30.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -11.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -6.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Bio-Path Holdings was 15.80% per year. The lowest was -11.80% per year. And the median was -0.75% per year.

As of today (2026-06-28), Bio-Path Holdings's current stock price is $0.03416. Bio-Path Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $149.15. Bio-Path Holdings's Cyclically Adjusted PB Ratio of today is 0.00.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Path Holdings was 14.93. The lowest was 0.01. And the median was 0.29.


Bio-Path Holdings  (OTCPK:BPTH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bio-Path Holdings's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.03416/149.15
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Path Holdings was 14.93. The lowest was 0.01. And the median was 0.29.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bio-Path Holdings Cyclically Adjusted Book per Share Related Terms


Bio-Path Holdings Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bio-Path Holdings's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Path Holdings Cyclically Adjusted Book per Share Chart

Bio-Path Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 310.74 312.42 320.21 305.39 214.03

Bio-Path Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 214.03 195.88 178.20 162.05 149.15

BPTH vs ADAPY, ZVSA, CLSDQ: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Bio-Path Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Path Holdings Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Path Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Path Holdings's Cyclically Adjusted PB Ratio falls into.



Bio-Path Holdings Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Path Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.908/330.2130*330.2130
=-0.908

Current CPI (Mar. 2026) = 330.2130.

Bio-Path Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201603 365.727 238.132 507.146
201606 287.591 241.018 394.022
201609 390.708 241.428 534.391
201612 343.333 241.432 469.586
201703 337.167 243.801 456.671
201706 354.200 244.955 477.481
201709 261.960 246.819 350.470
201712 288.107 246.524 385.912
201803 224.107 249.554 296.541
201806 169.179 251.989 221.697
201809 90.545 252.439 118.441
201812 35.824 251.233 47.086
201903 142.858 254.202 185.575
201906 126.148 256.143 162.627
201909 111.278 256.759 143.113
201912 113.978 256.974 146.462
202003 96.930 258.115 124.005
202006 86.546 257.797 110.857
202009 71.276 260.280 90.427
202012 66.388 260.474 84.163
202103 90.152 264.877 112.389
202106 85.500 271.696 103.915
202109 81.972 274.310 98.677
202112 71.109 278.802 84.221
202203 62.332 287.504 71.591
202206 54.525 296.311 60.763
202209 45.243 296.808 50.335
202212 35.613 296.797 39.623
202303 22.882 301.836 25.033
202306 12.671 305.109 13.714
202309 4.407 307.789 4.728
202312 0.714 306.746 0.769
202403 -3.481 312.332 -3.680
202406 0.565 314.175 0.594
202409 -0.192 315.301 -0.201
202412 0.027 315.605 0.028
202503 -0.312 319.799 -0.322
202506 -0.862 322.561 -0.882
202509 -0.866 324.800 -0.880
202603 -0.908 330.213 -0.908

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $149.15 mean?
Bio-Path Holdings (BPTH) has a Cyclically Adjusted Book per Share of $149.15 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Path Holdings and its competitors.
Is Bio-Path Holdings' Cyclically Adjusted Book per Share too high?
Bio-Path Holdings' current Cyclically Adjusted Book per Share is $149.15.
How does Bio-Path Holdings' Cyclically Adjusted Book per Share compare to ADAPY and ZVSA?
Bio-Path Holdings' Cyclically Adjusted Book per Share of $149.15 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Path Holdings and its competitors. Bio-Path Holdings's current Cyclically Adjusted Book per Share is $149.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Path Holdings stock overvalued right now?
Bio-Path Holdings (BPTH) has a current Cyclically Adjusted Book per Share of $149.15. The current Cyclically Adjusted Book per Share is $149.15. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bio-Path Holdings (BPTH), the current Cyclically Adjusted Book per Share is $149.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Path Holdings Business Description

Address No. 2407, 625 Stanwix Street, Pittsburgh, PA, USA, 15222
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.